U-M Injury Prevention Center compilation of data from state and federal sources will serve as baseline for future studies.
Unless Congress closes a loophole in the orphan drug law, new products containing the opioid addiction treatment buprenorphine could be blocked from the market until 2024.
Diagnoses of mental health and substance use disorders associated with three times higher odds of overdose.
As the opioid crisis unfolded, prescriptions for the narcotic alternative saw a two-fold increase despite unclear evidence of benefit for pain.
U-M Pediatrician: Government Missed Opportunity to Improve Care for Children With Sickle Cell Disease
Despite efforts to improve the standard of care for children with sickle cell disease, the nation falls short, says pediatrician
Insurance records reveal patterns of opioid prescribing to patients whose family members “shop” for opioids from multiple sources